^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

APOBEC3G (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3G)

i
Other names: APOBEC3G, Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3G, CEM15, DNA DC->DU-Editing Enzyme APOBEC-3G, DJ494G10.1, BK150C2.7, MDS019, Apolipoprotein B MRNA Editing Enzyme, Catalytic Polypeptide-Like 3G, APOBEC-Related Cytidine Deaminase, APOBEC-Related Protein 9, Deoxycytidine Deaminase, FLJ12740, CEM-15, ARP-9, ARCD, A3G, Apolipoprotein B Editing Enzyme Catalytic Polypeptide-Like 3G, Apolipoprotein B MRNA-Editing Enzyme Catalytic Polypeptide 3G, Apolipoprotein B MRNA Editing Enzyme Cytidine Deaminase, Phorbolin-Like Protein MDS019, DNA DC->DU Editing Enzyme, APOBEC-Related Protein, ARP9
Associations
3ms
Proteome-wide mendelian randomization identifies FCRL3 and LY9 as potential therapeutic targets for lymphoma. (PubMed, Discov Oncol)
Our study identified 37 potential lymphoma drug targets, emphasizing FCRL3 and LY9 as valuable therapeutic candidates, and amiodarone and chrysin in clinical translational application.
Journal
|
LY9 (Lymphocyte Antigen 9) • LY75 (Lymphocyte Antigen 75) • APOBEC3G (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3G) • MAPK3 (Mitogen-Activated Protein Kinase 3)
5ms
Integration of eQTL and GEO Datasets to Identify Genes Associated with Breast Ductal Carcinoma In Situ. (PubMed, Curr Issues Mol Biol)
Thirteen genes were associated with DCIS progression, and six genes were validated in the cell experiments. KEGG and GO analyses highlight TME's role in early breast cancer, enhancing understanding of DCIS occurrence and aiding identification of high-risk tumors.
Journal
|
PTPN12 (Protein Tyrosine Phosphatase Non-Receptor Type 12) • APOBEC3G (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3G) • CYB5R2 (Cytochrome B5 Reductase 2) • GPX3 (Glutathione Peroxidase 3) • YTHDC2 (YTH N6-Methyladenosine RNA Binding Protein C2)
7ms
TRDMT1 methyltransferase gene knockout attenuates STING-based cell death signaling during self-extracellular RNA-mediated response in drug-induced senescent osteosarcoma cells. (PubMed, Cell Mol Life Sci)
In the present study, self-extracellular RNA was obtained from dying (RNA D) and senescent (RNA S) cellular models of osteosarcoma (OS), characterized by NGS, and tested against proliferating and non-proliferating (etoposide-indued senescent) OS cells (U-2 OS, SaOS-2, MG-63, 143B)...TRDMT1 KO also resulted in replication stress in OS cells that was potentiated by RNA D and RNA S stimulation and associated with elevated levels of APOBEC3A and APOBEC3G, members of the cytidine deaminase protein family. In conclusion, we showed that TRDMT1 KO restricted STING-based immune and cell death response to RNA D and RNA S in non-proliferating drug resistant OS cells that might have potential therapeutic implications.
Journal
|
RAD51 (RAD51 Homolog A) • STING (stimulator of interferon response cGAMP interactor 1) • CDKN1A (Cyclin-dependent kinase inhibitor 1A) • APOBEC3A (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3A) • APOBEC3G (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3G) • IFNB1 (Interferon Beta 1) • NSUN5 (NOP2/Sun RNA Methyltransferase 5)
|
etoposide IV
11ms
Comprehensive Analysis of Roles of APOBEC3 Gene Family in Clear Cell Renal Cell Carcinoma. (PubMed, Arch Esp Urol)
These study findings suggest that APOBEC3 genes are commonly overexpressed in ccRCC, and their expression levels are associated with poor prognosis in ccRCC, somatic gene mutations, cancer immunomodulation, and immune cell infiltration levels in the tumor microenvironment.
Journal
|
PBRM1 (Polybromo 1) • BAP1 (BRCA1 Associated Protein 1) • SETD2 (SET Domain Containing 2, Histone Lysine Methyltransferase) • APOBEC3B (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3B) • APOB (Apolipoprotein B) • APOBEC3A (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3A) • APOBEC3G (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3G) • APOBEC3H (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3H)
|
VHL mutation
11ms
RNA-binding protein expression based machine learning model predicts metastasis and treatment outcome of testicular cancer. (PubMed, Genes Genomics)
RBP signature genes can serve as biomarkers for testicular cancer and play a role in predicting tumor metastasis and therapeutic efficacy.
Journal • PD(L)-1 Biomarker • IO biomarker
|
LDHB (L-lactate dehydrogenase B chain) • ENO1 (Enolase 1) • BICD1 (BICD Cargo Adaptor 1) • GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase) • APOBEC3G (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3G) • KRT18 (Keratin 18) • TCF7 (Transcription Factor 7)
|
cisplatin • bleomycin
over1year
Validation of the APOBEC3A-mediated RNA Single Base Substitution Signature and Proposal of Novel APOBEC1, APOBEC3B, and APOBEC3G RNA Signatures. (PubMed, J Mol Biol)
Here, we provide the first validation of an RNA-SBS mutational signature by decomposing novel exogenous and endogenous APOBEC3A RNA editing signatures into COSMICv3.4 RNA-SBS reference signatures. Additionally, we have identified novel RNA-SBS signatures for APOBEC1, APOBEC3B, and APOBEC3G.
Journal
|
APOBEC3B (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3B) • APOB (Apolipoprotein B) • APOBEC1 (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 1) • APOBEC3A (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3A) • APOBEC3G (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3G)
over1year
Molecular mechanism for regulating APOBEC3G DNA editing function by the non-catalytic domain. (PubMed, Nat Commun)
We present two co-crystal structures of rhesus macaque APOBEC3G bound to ssDNA containing AA and GA, revealing the contribution of the non-catalytic domain in capturing AA/GA DNA. Our findings elucidate the molecular mechanism of APOBEC3G's cooperative function, which is critical for its antiviral role and its contribution to mutations in cancer genomes.
Journal
|
APOBEC3G (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3G)
over1year
Highly homologous simian T-cell leukemia virus type 1 genome in Japanese macaques: a large cohort study. (PubMed, Virol J)
Taken together, these results indicate that STLV-1 genomes in JMs are highly homologous, at least in part due to the lack of Apobec3G-dependent G-to-A hypermutation.
Journal
|
APOBEC3G (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3G)
over1year
Prevalence of HBsAg among Moroccan HIV-1 infected patients and APOBEC3G variant frequencies in HIV-1/HBV co-infection. (PubMed, J Infect Dev Ctries)
HBV co-infection is common among HIV-1 infected individuals in Morocco. Efforts should be made to prevent, treat and control HBV transmission in this population.
Journal
|
APOBEC3G (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3G)
almost2years
Genome-wide identification and analysis of epithelial-mesenchymal transition-related RNA-binding proteins and alternative splicing in a human breast cancer cell line. (PubMed, Sci Rep)
Conclusively, eight RBPs such as RBMS3 and AS of TNC and COL6A3 could be used as predictors of breast cancer prognosis. These findings need to be further explored as possible targets for breast cancer treatment.
Preclinical • Journal
|
COL6A3 (Collagen Type VI Alpha 3 Chain) • PAICS (Phosphoribosylaminoimidazole Carboxylase And Phosphoribosylaminoimidazolesuccinocarboxamide Synthase) • RBMS3 (RNA Binding Motif Single Stranded Interacting Protein 3) • ACO1 (Aconitase 1) • APOBEC3G (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3G) • ITGA6 (Integrin, alpha 6) • ADGRE5 (Adhesion G Protein-Coupled Receptor E5)
almost2years
The implications of APOBEC3-mediated C-to-U RNA editing for human disease. (PubMed, Commun Biol)
These polymorphisms are associated with over 20% of Medical Subject Headings across ten categories of disease, including nutritional and metabolic, neoplastic, cardiovascular, and nervous system diseases. Because RNA editing is transient and not organism-wide, future work is necessary to confirm the extent and effects of such editing in humans.
Journal
|
APOBEC3A (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3A) • APOBEC3G (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3G)
almost2years
Protein interaction map of APOBEC3 enzyme family reveals deamination-independent role in cellular function. (PubMed, Mol Cell Proteomics)
Altogether, the results uncover novel functions and interactions of the APOBEC3 family and suggest they may have fundamental roles in cellular RNA biology, their protein-protein interactions are not redundant, and there are protein-protein interactions with tumor suppressors, suggesting a role in cancer biology. Data are available via ProteomeXchange with identifier PXD044275.
Journal
|
MYC (V-myc avian myelocytomatosis viral oncogene homolog) • APOBEC3B (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3B) • APOBEC3G (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3G) • APOBEC3H (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3H)